Download Files:
BI-1935
SKU
HY-124063-10 mg
Category Reference compound
Tags Cardiovascular Disease, Epoxide Hydrolase, Metabolic Enzyme/Protease
$350 – $2,450
Products Details
Product Description
– BI-1935 is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease[1].
Web ID
– HY-124063
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C24H21F3N6O3
References
– [1]Roman Wolfgang Fleck, et al. Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors. WO2007067836A2.
CAS Number
– 940954-41-6
Molecular Weight
– 498.46
Compound Purity
– 98.08
SMILES
– O=C(C(C=C1)=CN(CCOCC)C1=O)NC2=NC=C(N3N=C(C4=CC=CN=C4)C=C3C(F)(F)F)C=C2
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Epoxide Hydrolase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.